Retifanlimab and Ruxolitinib In Solid Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Retifanlimab and Ruxolitinib In Solid Malignancies	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, urinary system disorder	Recruiting	Phase 1 / Phase 2	2026-01-13		NCT07219576

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Incyte Corporation	153
University of California, San Diego	337

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of California, San Diego Moores Cancer Center	La Jolla	United States	5